Literature DB >> 34407383

Hepatitis B virus infection seromarkers among college freshmen and their immune responses to different vaccination policies of hepatitis B vaccine.

Yuyang Xu1, Yan Liu1, Jun Wang1, Xinren Che1, Xuechao Zhang1, Wei Jiang1, Jian Du1, Xiaoping Zhang1, Wenwen Gu1.   

Abstract

BACKGROUND: College students are one of the susceptible population of Hepatitis B virus (HBV) infection. We aim to delineate HBV infection seromarkers among college freshmen and to evaluate immunological response of vaccination immunization for hepatitis B vaccine (HepB).
METHODS: A simple random sampling method was adopted to select subjects and who met the "inclusion and exclusion criteria" and who with history of vaccination were selected as the observation objects. HBsAg and anti-HBs levels were detected before revaccination. Subjects with negative anti-HBs before immunization were inoculated with 20 ug HepB according to the 0-1-6 procedure and those with weak positive anti-HBs before immunization were inoculated with 1-dose 20 ug HepB. Anti-HBs levels were detected after HepB booster. Combined with the results of anti-HBs, their immune response to HepB and influencing factors in freshmen were investigated. Anti-HBs before immunization was negative and ≥10 m IU/ml after immunization was considered positive conversion; anti-HBs before immunization was weak positive and anti-HBs≥100 m IU/ml after immunization was also considered positive conversion.
RESULTS: A total of 10645 freshmen were included. The total rate of HBsAg carriers was 0.6% (63/10645), and the strong positive rate of anti-HBs was 16.1% (1706/10645), the weak positive rate was 14.4% (1526/10645).1286 freshmen were vaccinated with HepB and completed the questionnaire survey. About 79.0% (154/195) of freshmen's anti-HBs turned strong positive after receiving 1-dose HepB and 100.0% (1091/1091) turned positive after receiving 3-doses HepB. The Geometrical Mean Titer (GMT) of anti-HBs was significantly influenced by gender, registration and the immunization doses of HepB.
CONCLUSION: The HBsAg carrying rate and anti-HBs positive rate of college freshmen were low, and the HepB has a good effect on the immunity of college freshmen. Increasing the immunization rate of HepB is very important for the prevention and control of hepatitis B.

Entities:  

Keywords:  HBV infection seromarkers; Hepatitis B; college freshmen; long-term immunity response; vaccination policy

Mesh:

Substances:

Year:  2021        PMID: 34407383      PMCID: PMC8828073          DOI: 10.1080/21645515.2021.1959829

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  15 in total

1.  Minimization of hepatitis B infection by a 25-year universal vaccination program.

Authors:  Yen-Hsuan Ni; Mei-Hwei Chang; Jia-Feng Wu; Hong-Yuan Hsu; Huey-Ling Chen; Ding-Shinn Chen
Journal:  J Hepatol       Date:  2012-06-02       Impact factor: 25.083

2.  Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: A 2-year follow-up study.

Authors:  Zhen-Zi Wang; Yu-Hua Gao; Ping Wang; Lin Wei; Chang-Ping Xie; Zhen-Xing Yang; Jian Lan; Zhong-Liao Fang; Ying Zeng; Ling Yan; Xue-En Liu; Hui Zhuang
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

Review 3.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

4.  [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].

Authors:  Wei Zhang; Chang-ying Lin; Li-li Han; Li-qiu Li; Pei Gao; Hui Lin; Xiao-hong Gong; Fang Huang; Ya-qing Tang; Jian-xin Ma; Hai-yan Zhang; Chen Wang; Peng Yang; Hui Li; Mei-ping Sun; Xiong He; Xing-huo Pang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2010-07

5.  Awareness and knowledge of hepatitis B infection and prevention and the use of hepatitis B vaccination in the Hong Kong adult Chinese population.

Authors:  Pui Wah Chung; Sik Hung Suen; Oi Ka Chan; Tzu Hsi Lao; Tak Yeung Leung
Journal:  Chin Med J (Engl)       Date:  2012-02       Impact factor: 2.628

6.  Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China.

Authors:  Liping Shen; Fuzhen Wang; Feng Wang; Fuqiang Cui; Shuang Zhang; Hui Zheng; Yong Zhang; Xiaofeng Liang; Shengli Bi
Journal:  Vaccine       Date:  2012-09-07       Impact factor: 3.641

7.  Chronic hepatitis B infection in adolescents who received primary infantile vaccination.

Authors:  Tzu-Wei Wu; Hans Hsienhong Lin; Li-Yu Wang
Journal:  Hepatology       Date:  2012-12-28       Impact factor: 17.425

8.  Three decades of neonatal vaccination has greatly reduced antenatal prevalence of hepatitis B virus infection among gravidae covered by the program.

Authors:  Terence T Lao; Daljit S Sahota; Paul K S Chan
Journal:  J Infect       Date:  2018-05-06       Impact factor: 6.072

9.  Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

Authors:  Jinlin Hou; Guiqiang Wang; Fusheng Wang; Jun Cheng; Hong Ren; Hui Zhuang; Jian Sun; Lanjuan Li; Jie Li; Qinghua Meng; Jingmin Zhao; Zhongping Duan; Jidong Jia; Hong Tang; Jifang Sheng; Jie Peng; Fengmin Lu; Qing Xie; Lai Wei
Journal:  J Clin Transl Hepatol       Date:  2017-11-12

10.  Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China.

Authors:  Fuqiang Cui; Lipin Shen; Li Li; Huaqing Wang; Fuzhen Wang; Shengli Bi; Jianhua Liu; Guomin Zhang; Feng Wang; Hui Zheng; Xiaojin Sun; Ning Miao; Zundong Yin; Zijian Feng; Xiaofeng Liang; Yu Wang
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

View more
  1 in total

1.  Analysis of Knowledge, Attitude and Practice of Hepatitis B Among Freshmen in Jiangsu Based on Lasso-Logistic Regression and Structural Equation Model.

Authors:  Fulai Tu; Ruizhe Yang; Weixiang Wang; Rui Li; Guoping Du; Yangyang Liu; Wei Li; Pingmin Wei
Journal:  Infect Drug Resist       Date:  2022-06-15       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.